Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma | Caris Life Sciences
Home / Research / Publications / Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma

Publications

Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma

  • Cholangiocarcinoma (CCA) has one of the fastest rising incidence rates (8% APR) among early-onset (eo) cancers.
  • Real-world age-stratified multi-omic characterization of eoCCA could reveal molecular features with prognostic and therapeutic implications.
  • We sought to compare the molecular characteristics of eoCCA with average-onset CCA (aoCCA) utilizing a realworld multi-omics dataset.
Download Publication
Learn More
Name(Required)